re: DEA announces that marijuana will remain a Schedule 1 drug - like LSD & heroin

quote:

---

Taurus is anti-pot? No way.
Surprised me, too. He's such a cool customer.

---

I wonder how much personal pot experience Taurus has.

quote:

---

Look it up lazy arse.

---

Says the person who referred to the study but is too lazy to link it.

quote:

---

Google it. They are are out there. Pot is addictive. Look it up lazy arse.

---

O the irony

quote:

---

FYI the DEA is led by Obama appointees.

---

and created under a republican president.

Well what else is new. What morons

People I know don't suck dick for pot. But crack is a schedule II drug, and MJ schedule I?

Pot heads don't loose teeth like meth heads, either.

I love the the enforcement agency makes essentially scientific determinations on this. Like they would ever lower the schedule to their own detriment.

quote:

---

Sugar is addictive.

Caffeine is addictive.

Food is addictive.

How far into people's private lives do you need the government to reach in order to feel safe?

---

Authoritarians make my blood boil.

First, I am not anti- or pro- weed, though I find it incredibly disingenuous the number of people screaming for the legalization of "medicinal" marijuana as a means to recreational use. Just be honest. Second, all of the conspiracy theories about government and big pharma are amusing. The marijuana plant is schedule I and should be because it has no FDA approved medical indication. Synthetic THC is an approved FDA drug and is not schedule I. Meth is schedule II because it also has an FDA approved indication and is sold as Desoxyn. The FDA and government are not trying to prevent the legalization of cannabinoids. I don't have any colleagues that deny the potential utility of drugs targeting the cannabinoid system (CB1 or CB2). Sativex (Nabiximols) is approved in the UK, parts of Europe and Canada. It is a spray combination of 1:1 THC and CBD. The FDA granted it "fast track" review status for cancer pain. The phase III trial ended at the end of 2015. Bad news, the results of the trial showed no benefit over placebo, and far inferior performance to the control of pain with opioids. We have a very rigorous process for the approval of pharmaceuticals and there have been no large-scale (successful) trials of medicinal marijuana that would compel its approval beyond currently available treatments. I suspect Sativex will continue to seek approval for a number of other indications in future trials.